Project Details
| Short title | VNC-236-101 |
|---|---|
| Status | Active |
| Effective start/end date | 12/09/23 → 26/07/28 |
CTU: An open-label, multicenter Phase 1 study to characterize safety, tolerability, preliminary antitumor activity, pharmacokinetics, and pharmacodynamics of VIP236 monotherapy in subjects with advanced cancer
- Park, John (Primary Chief Investigator)
- Chapman, Nicola (Clinical Trial Unit Staff)
- Contacos, Christine (Clinical Trial Unit Staff)
- TAIDI, Gina (Clinical Trial Unit Staff)
- Chester, Catherine (Clinical Trial Unit Staff)
Project: Research